Anti-Vascular Endothelial Growth Factor Comparative Effectiveness Trial for Diabetic Macular Edema: Additional Efficacy Post Hoc Analyses of a Randomized Clinical Trial

IMPORTANCE: Post-hoc analyses from DRCR.net randomized trial comparing aflibercept, bevacizumab, and ranibizumab for diabetic macular edema (DME) might influence interpretation of study results. OBJECTIVE: To provide additional post-hoc clinically relevant outcomes comparing three anti-VEGF agents f...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:JAMA Ophthalmol
Main Authors: Jampol, Lee M., Glassman, Adam R., Bressler, Neil M., Wells, John A., Ayala, Allison R.
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5567802/
https://ncbi.nlm.nih.gov/pubmed/27711918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaophthalmol.2016.3698
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki